Related Experiment Video
Updated: Aug 5, 2025

09:25
The Treadmill Fatigue Test: A Simple, High-throughput Assay of Fatigue-like Behavior for the Mouse
Published on: May 31, 2016
18.9K
Curcumin (CUMINUP60®) mitigates exercise fatigue through regulating PI3K/Akt/AMPK/mTOR pathway in mice.
Minghui Hu1,2, Muxuan Han3, Hao Zhang1,2
1Experimental Center, Shandong University of Traditional Chinese Medicine, Ji’nan, China.
Aging
|March 29, 2023
Summary
Curcumin, derived from turmeric, effectively combats exercise fatigue in mice by regulating energy metabolism. It enhances endurance and muscle function, similar to caffeine, by influencing key cellular pathways.
Area of Science:
- Exercise Physiology
- Molecular Biology
- Pharmacology
Background:
- Curcumin, a compound from Curcuma longa L., shows potential in mitigating exercise fatigue.
- The precise molecular mechanisms underlying curcumin's anti-fatigue effects remain largely unexplored.
Purpose of the Study:
- To investigate the molecular mechanisms of curcumin's anti-fatigue effects using a mouse model.
- To compare curcumin's efficacy against caffeine, a known ergogenic aid.
Main Methods:
- Kunming mice were administered curcumin or caffeine intragastrically for 28 days.
- Exercise fatigue was assessed by measuring time to exhaustion, muscle glycogen, and protein expression.
- Key metabolic markers including AMP/ATP ratio, lactic acid, glycogen synthase, and myonectin were analyzed.
Main Results:
- Both curcumin and caffeine significantly improved exercise performance and increased muscle glycogen content compared to controls.
- Curcumin demonstrated superior effects in reducing the AMP/ATP ratio and lactic acid levels.
- Curcumin modulated the PI3K/Akt/AMPK/mTOR signaling pathway, influencing protein expression related to energy metabolism.
Conclusions:
- Curcumin exhibits significant anti-fatigue properties comparable to caffeine.
- Curcumin's mechanism involves the regulation of energy metabolism via the PI3K/Akt/AMPK/mTOR pathway.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
3.8K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K

